Use of human blood coagulation factor XIII for the treatment of ulcerative colitis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 3, 1995
Issued Date -
N/A
app pub date -
May 13, 1993
filing date -
Feb 9, 1987
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Use of human blood coagulation factor XIII for the treatment of ulceration colitis The use of human blood coagulation factor XIII for the treatment of ulcerative colitis is demonstrated in 4 representative cases. Treatment with factor XIII leads to rapid and total disappearence of the chief symptoms realizing transition to the remission stage.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully